Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger protein 205 (ZNF205) is a human transcription factor belonging to the zinc finger protein family, predicted to enable sequence-specific DNA binding and regulation of RNA polymerase II-mediated gene transcription[1][3][7]. It acts mainly as a transcriptional repressor, influencing the expression of genes such as MPV17L, thus modulating cellular processes including hydrogen peroxide metabolism, mitochondrial outer membrane permeabilization, and the intrinsic apoptotic pathway[1][3][7]. ZNF205 is linked to cancer and developmental disorders, but there are no known drug interactions or therapeutic targeting strategies as of current data[1][3][4][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein 205 (ZNF205).